Skip to main content
Journal cover image

DUOC-01, a cord blood derived cell therapy product, ameliorates experimental autoimmune encephalomyelitis, a murine model for multiple sclerosis

Publication ,  Conference
Saha, A; Scotland, P; Parrott, R; Schwartzman, J; Xu, L; Filiano, AJ; Kurtzberg, J
Published in: CYTOTHERAPY
2020

Duke Scholars

Published In

CYTOTHERAPY

EISSN

1477-2566

ISSN

1465-3249

Publication Date

2020

Volume

22

Issue

5

Start / End Page

S31 / S32

Related Subject Headings

  • Immunology
  • 3206 Medical biotechnology
  • 3204 Immunology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Saha, A., Scotland, P., Parrott, R., Schwartzman, J., Xu, L., Filiano, A. J., & Kurtzberg, J. (2020). DUOC-01, a cord blood derived cell therapy product, ameliorates experimental autoimmune encephalomyelitis, a murine model for multiple sclerosis. In CYTOTHERAPY (Vol. 22, pp. S31–S32).
Saha, A., P. Scotland, R. Parrott, J. Schwartzman, L. Xu, A. J. Filiano, and J. Kurtzberg. “DUOC-01, a cord blood derived cell therapy product, ameliorates experimental autoimmune encephalomyelitis, a murine model for multiple sclerosis.” In CYTOTHERAPY, 22:S31–32, 2020.
Saha A, Scotland P, Parrott R, Schwartzman J, Xu L, Filiano AJ, et al. DUOC-01, a cord blood derived cell therapy product, ameliorates experimental autoimmune encephalomyelitis, a murine model for multiple sclerosis. In: CYTOTHERAPY. 2020. p. S31–2.
Saha A, Scotland P, Parrott R, Schwartzman J, Xu L, Filiano AJ, Kurtzberg J. DUOC-01, a cord blood derived cell therapy product, ameliorates experimental autoimmune encephalomyelitis, a murine model for multiple sclerosis. CYTOTHERAPY. 2020. p. S31–S32.
Journal cover image

Published In

CYTOTHERAPY

EISSN

1477-2566

ISSN

1465-3249

Publication Date

2020

Volume

22

Issue

5

Start / End Page

S31 / S32

Related Subject Headings

  • Immunology
  • 3206 Medical biotechnology
  • 3204 Immunology
  • 1103 Clinical Sciences